Founders Fund Growth II Management, LP — Full 13F Portfolio Breakdown

CIK: 0002106825

High-turnover trader

Total reported value

—

Reporting period: 2026-03-31 · Number of holdings: 1

Founders Fund Growth II Management, LP disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 100.0%.

Browse other institutions starting with "F"

Personality snowflake

Concentration: 0
Portfolio Stability: 100
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 2
Sizing Uniformity: —

Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

Recent moves

Sold out BMNR
Unchanged 000000000

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	✓	Ikena Oncology INC	Stock-Other	—	—	—

Portfolio Performance

Performance for Q3 2026

-10%

Performance Last 4 Quarters

+1.5%

Based on 3 months of available history

Stdev: +33%
Beta: +0.03
Alpha: +8.5%
Max Drawdown: -10%
Annualized Perf: +6.3%
Batting Avg vs S&P: +33.3%
Sortino: +0.49
Stutzer: —
Treynor: +3.24
Sterling: —
Calmar: +0.63
Information Ratio: -0.79
Tracking Error: +42.3%
Stdev Down: +19.9%
Winning Months %: +66.7%
Losing Months %: +33.3%
Best 12 Months: —
Worst 12 Months: —
Efficiency Ratio: +0.07
Sharpe: +0.3
Stdev Sectors: —
Skewness: -0.57
Kurtosis: -1.5
Upside Potential: +2.49

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	1	—	100
2025-12-31	1	$23.7M	0	1BMNR Top holdings2025-12-31 1.BMNR

Holding changes this quarter

Founders Fund Growth II Management, LP's most significant position changes for 2026-03-31: Sold out: Bitmine Immersion Technologi (BMNR).

Position changes disclosed by Founders Fund Growth II Management, LP for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	BMNR	Bitmine Immersion Technologi	—	EXIT	Sold out
2	✓	Ikena Oncology INC	—	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2026-03-31	2026-05-15	13F-HR	View on EDGAR
2025-12-31	2026-02-17	13F-HR	View on EDGAR

FAQ

What is Founders Fund Growth II Management, LP and what type of investor is it?

Founders Fund Growth II Management, LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.

What are Founders Fund Growth II Management, LP's largest equity positions?

Based on the latest 13F filing, Founders Fund Growth II Management, LP's top holdings by market value are: 1. Ikena Oncology INC — $0.0

What changes did Founders Fund Growth II Management, LP make in its most recent portfolio filing?

In the latest quarter, Founders Fund Growth II Management, LP took a more defensive posture — trimming 0 positions and completely exiting 1 holdings. The largest of these moves: Sold out: Bitmine Immersion Technologi (BMNR)

What sectors does Founders Fund Growth II Management, LP focus on?

Sector breakdown data is not yet available for Founders Fund Growth II Management, LP. Check back after the next 13F processing cycle.

Peer Institutions

Institutions with a similar AUM

Cowen And Company, LLC

CIK 0000048966

Total reported value

—

1 stks

2024-12-31

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Kresge Foundation

CIK 0000056822

Total reported value

—

1 stks

2019-12-31

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Resource America, INC.

CIK 0000083402

Total reported value

—

1 stks

2021-09-30

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Personality snowflake

Concentration

Portfolio Stability

100

Momentum/Contrarian

Sector conviction

Diversification

Sizing Uniformity

—

Ticker

Issuer

Asset Subclass

Weight

Weight Change

Shares Change

4Q Trend

✓

Ikena Oncology INC

Stock-Other

—

Portfolio Performance

Performance for Q3 2026

-10%

Performance Last 4 Quarters

+1.5%

Based on 3 months of available history

Stdev: +33%
Beta: +0.03
Alpha: +8.5%
Max Drawdown: -10%
Annualized Perf: +6.3%
Batting Avg vs S&P: +33.3%
Sortino: +0.49
Stutzer: —
Treynor: +3.24
Sterling: —
Calmar: +0.63
Information Ratio: -0.79
Tracking Error: +42.3%
Stdev Down: +19.9%
Winning Months %: +66.7%
Losing Months %: +33.3%
Best 12 Months: —
Worst 12 Months: —
Efficiency Ratio: +0.07
Sharpe: +0.3
Stdev Sectors: —
Skewness: -0.57
Kurtosis: -1.5
Upside Potential: +2.49

Period

Holdings

Total value

Stability

Top holdings

2026-03-31

—

100

2025-12-31

$23.7M

1BMNR

Ticker

Issuer

Weight Change

Shares Change

Action

BMNR

Bitmine Immersion Technologi

—

EXIT

Sold out

✓

Ikena Oncology INC

—

Unchanged

Period

Filed

Type

EDGAR

2026-03-31

2026-05-15

13F-HR

View on EDGAR

2025-12-31

2026-02-17

13F-HR

View on EDGAR

FAQ

What is Founders Fund Growth II Management, LP and what type of investor is it?

What are Founders Fund Growth II Management, LP's largest equity positions?

Based on the latest 13F filing, Founders Fund Growth II Management, LP's top holdings by market value are: 1. Ikena Oncology INC — $0.0

What changes did Founders Fund Growth II Management, LP make in its most recent portfolio filing?

What sectors does Founders Fund Growth II Management, LP focus on?

Sector breakdown data is not yet available for Founders Fund Growth II Management, LP. Check back after the next 13F processing cycle.